Atlas Trials

Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections

Clinical trial NCT02959957 · COMPLETED

Trial details

NCT number
NCT02959957
Sponsor
Håkan Hanberger
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Urinary Tract Infections
Start date
2016-05-20
Primary completion
2019-08-01
Enrollment
157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.